Butylated hydroxytoluene analogs: Synthesis and evaluation of their multipotent antioxidant activities

Molecules

Volumn 17, Issue 7, 2012, Pages 7645-7665

  Yehye, Wageeh A ^a   Rahman, Noorsaadah Abdul ^a   Alhadi, Abeer A ^a   Khaledi, Hamid ^a   Ng, Seik Weng ^a,b   Ariffin, Azhar ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

1,2,4 triazole; 1,3,4 thiadiazole; Butylated hydroxyltolouene; DPPH; Drug likeness properties; Lipid peroxidation; Multipotent antioxidant; PASS and activity prediction; Rule of five; Thiosemicarbazide

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ANTIOXIDANT; BIPHENYL DERIVATIVE; BUTYLCRESOL; DRUG DERIVATIVE; PICRIC ACID; PROSTAGLANDIN SYNTHASE INHIBITOR; SCAVENGER;

ARTICLE; CHEMISTRY; CONFORMATION; DRUG EFFECT; HYDROGEN BOND; IC 50; LIPID PEROXIDATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANTIOXIDANTS; BIPHENYL COMPOUNDS; BUTYLATED HYDROXYTOLUENE; CRYSTALLOGRAPHY, X-RAY; CYCLOOXYGENASE INHIBITORS; FREE RADICAL SCAVENGERS; HYDROGEN BONDING; INHIBITORY CONCENTRATION 50; LIPID PEROXIDATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; PICRATES; STEREOISOMERISM;

EID: 84864609661     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17077645     Document Type: Article

References (82)

1. Schöneich, C. Reactive oxygen species and biological aging: A mechanistic approach. Exp. Gerontol. 1999, 34, 19-34. (Pubitemid 29085065)
2. Sahinoglu, T.; Stevens, C.R.; Bhatt, B.; Blake, D.R. The role of reactive oxygen species in inflammatory disease: Evaluation of methodology. Methods 1996, 9, 628-634. (Pubitemid 26273481)
3. Schöneich, C. Methionine oxidation by reactive oxygen species: Reaction mechanisms and relevance to alzheimer's disease. Biochim. Biophys. Acta 2005, 1703, 111-119. (Pubitemid 40170434)
4. Oka, M.; Tachibana, M.; Noda, K.; Inoue, N.; Tanaka, M.; Kuwabara, K. Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of eviprostat, a phytotherapeutic agent for benign prostatic hyperplasia. Phytomedicine 2007, 14, 465-472. (Pubitemid 47068955)
5. Kirkinezos, I.G.; Moraes, C.T. Reactive oxygen species and mitochondrial diseases. Semin. Cell Dev. Biol. 2001, 12, 449-457.
6. de Maria, N.; Colantonl, A.; Fagiuoli, S.; Liu, G.-J.; Rogers, B.K.; Farinati, F.; van Thiel, D.H.; Floyd, R.A. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic. Biol. Med. 1996, 21, 291-295. (Pubitemid 26271718)
7. Smith, C.; Zhang, Y.; Koboldt, C.; Muhammad, J.; Zweifel, B.; Shaffer, A.; Talley, J.; Masferrer, J.; Seibert, K.; Isakson, P. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 1998, 95, 13313-13318. (Pubitemid 28509568)
8. Shahidi, F.; Naczk, M.; Griffiths, W. Food Phenolics: Sources, Chemistry, Effects, Applications; Technomic Publishing: Lancaster, PA, USA, 1995.
9. Bandyopadhyay, M.; Chakraborty, R.; Raychaudhuri, U. A process for preparing a natural antioxidant enriched dairy product (sandesh). LWT-Food Sci. Technol. 2007, 40, 842-851. (Pubitemid 46275778)
10. Dacre, J. The metabolism of 3: 5-di-tert-butyl-4-hydroxytoluene and 3: 5-di-tert-butyl-4- hydroxybenzoic acid in the rabbit. Biochem. J. 1961, 78, 758-766.
11. Stecher, P. Butylated hydroxytoluene. In The Merck Index, 8th ed.; O'Neil, M.J., Ed.; Merck Research Laboratories: Rahway, NJ, USA, 1968; p. 179.
12. Lazer, E.S.; Wong, H.C.; Possanza, G.J.; Graham, A.G.; Farina, P.R. Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenols. J. Med. Chem. 1989, 32, 100-104.
13. Song, Y.; Connor, D.; Sercel, A.; Sorenson, R.; Doubleday, R.; Unangst, P.; Roth, B.; Beylin, V.; Gilbertsen, R.; Chan, K. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole series. J. Med. Chem. 1999, 42, 1161-1169. (Pubitemid 29181139)
14. Marnett, L.J.; Kalgutkar, A.S. Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents. Curr. Opin. Chem. Biol. 1998, 2, 482-490. (Pubitemid 128645701)
15. Inagaki, M.; Tsuri, T.; Jyoyama, H.; Ono, T.; Yamada, K.; Kobayashi, M.; Hori, Y.; Arimura, A.; Yasui, K.; Ohno, K. Novel antiarthritic agents with 1,2-isothiazolidine-1,1-dioxide ([gamma]-sultam) skeleton: Cytokine suppressive dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase. J. Med. Chem. 2000, 43, 2040-2048. (Pubitemid 30340943)
16. Unangst, P.C.; Shrum, G.P.; Connor, D.T.; Dyer, R.D.; Schrier, D.J. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors. J. Med. Chem. 1992, 35, 3691-3698.
17. Unangst, P.C.; Connor, D.T.; Cetenko, W.A.; Sorenson, R.J.; Kostlan, C.R.; Sircar, J.C.; Wright, C.D.; Schrier, D.J.; Dyer, R.D. Synthesis and biological evaluation of 5-[[3,5-bis(1,1- dimethylethyl)-4-hydroxyphenyl] methylene]oxazoles, -thiazoles, and -imidazoles: Novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity. J. Med. Chem. 1994, 37, 322-328. (Pubitemid 24063052)
18. Mullican, M.D.; Wilson, M.W.; Conner, D.T.; Kostlan, C.R.; Schrier, D.J.; Dyer, R.D. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally active, nonulcerogenic antiinflammatory agents. J. Med. Chem. 1993, 36, 1090-1099. (Pubitemid 23143622)
19. Leventis, I.; Andreadou, I.; Papalois, A.; Sfiniadakis, I.; Gorgoulis, V.; Korkolis, D.; Hadjipavlou-Litina, D.; Kourounakis, P.; Fotiadis, C. A novel antioxidant non-steroidal anti-inflammatory agent protects rat liver against ischemia-reperfusion injury. In Vivo 2004, 18, 161-169.
20. Weber, V.; Rubat, C.; Duroux, E.; Lartigue, C.; Madesclaire, M.; Coudert, P. New 3- and 4-hydroxyfuranones as anti-oxidants and anti-inflammatory agents. Bioorg. Med. Chem. 2005, 13, 4552-4564. (Pubitemid 40813243)
21. Amorati, R.; Lucarini, M.; Mugnaini, V.; Pedulli, G. Antioxidant activity of o-bisphenols: The role of intramolecular hydrogen bonding. J. Org. Chem. 2003, 68, 5198-5204. (Pubitemid 36750191)
22. Moore, G.; Swingle, K. 2,6-di-tert-butyl-4-(2-thenoyl)phenol(r-830): A novel nonsteroidal anti-inflammatory agent with antioxidant properties. Inflamm. Res. 1982, 12, 674-683. (Pubitemid 13115801)
23. Grosso, P.; Vogl, O. Functional polymers. Polym. Bull. 1985, 14, 245-250.
24. Zhang, H. Structure-activity relationships and rational design strategies for radical-scavenging antioxidants. Curr. Comput. Aided Drug Des. 2005, 1, 257-273.
25. Zhang, H.-Y.; Yang, D.-P.; Tang, G.-Y. Multipotent antioxidants: From screening to design. Drug Discov. Today 2006, 11, 749-754. (Pubitemid 44038625)
26. Kato, T.; Ozaki, T.; Tamura, K.; Suzuki, Y.; Akima, M.; Ohi, N. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3,5-di-tert-butyl-4-hydroxyphenyl)- 3-(aminopropyl) thiazolidinones. J. Med. Chem. 1998, 41, 4309-4316. (Pubitemid 28498754)
27. Dobek, A.; Klayman, D.; Dickson, E., Jr.; Scovill, J.; Oster, C. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-and 3-acetylisoquinoline and related compounds as inhibitors of clinically significant bacteria in vitro. Arzneimittelforschung 1983, 33, 1583-1591. (Pubitemid 14234221)
28. Eid, A.I.; Ragab, F.A.; El-Ansary, S.L.; El-Gazayerly, S.M.; Mourad, F.E. Synthesis of new 7-substituted 4-methylcoumarin derivatives of antimicrobial activity. Arch. Pharm. 1994, 327, 211-213. (Pubitemid 24111886)
29. Liesen, A.P.; de Aquino, T.M.; Carvalho, C.S.; Lima, V.T.; de Araújo, J.M.; de Lima, J.G.; de Faria, A.R.; de Melo, E.J.T.; Alves, A.J.; Alves, E.W.; et al. Synthesis and evaluation of anti-toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. Eur. J. Med. Chem. 2010, 45, 3685-3691.
30. Kus, C.; Ayhan-Kilcigil, G.; Eke, B.; i?can, M. Synthesis and antioxidant properties of some novel benzimidazole derivatives on lipid peroxidation in the rat liver. Arch. Pharm. Res. 2004, 27, 156-163. (Pubitemid 43093274)
31. Hussain, S.; Sharma, J.; Amir, M. Synthesis and antimicrobial activities of 1,2,4-triazole and 1,3,4-thiadiazole derivatives of 5-amino-2-hydroxybenzoic acid. E-J. Chem. 2008, 5, 963-968.
32. Vasoya, S.L.; Paghdar, D.J.; Chovatia, P.T.; Joshi, H.S. Synthesis of some new thiosemicarbazide and 1,3,4-thiadiazole heterocycles bearing benzo[b]thiophene nucleus as a potent antitubercular and antimicrobial agents. J. Sci. Islam. Repub. Iran 2005, 16, 33-36.
33. Rzeski, W.; Matysiak, J.; Kandefer-Szerszen, M. Anticancer, neuroprotective activities and computational studies of 2-amino-1,3,4- thiadiazole based compound. Bioorg. Med. Chem. 2007, 15, 3201-3207.
34. Abdel-Rahman, T.M. Synthesis, reactions, and anticancer activity of some 1,3,4-thiadiazole/ thiadiazine derivatives of carbazole. Phosphorus Sulfur Silicon Relat. Elem. 2006, 181, 1737-1754.
35. Khan, I.; Ali, S.; Hameed, S.; Rama, N.H.; Hussain, M.T.; Wadood, A.; Uddin, R.; Ul-Haq, Z.; Khan, A.; Ali, S.; et al. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5200-5207.
36. Palaska, E.; Sahin, G.; Kelicen, P.; Durlu, N.T.; Altinok, G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3- thiones. Il Farmaco 2002, 57, 101-107. (Pubitemid 34175107)
37. Navidpour, L.; Shafaroodi, H.; Abdi, K.; Amini, M.; Ghahremani, M.H.; Dehpour, A.R.; Shafiee, A. Design, synthesis, and biological evaluation of substituted 3-alkylthio-4,5-diaryl-4h-1,2,4- triazoles as selective COX-2 inhibitors. Bioorg. Med. Chem. 2006, 14, 2507-2517. (Pubitemid 43343637)
38. Wujec, M.; Pitucha, M.; Dobosz, M.; Kosikowska, U.; Malm, A. Synthesis and potential antimycotic activity of 4-substituted-3-(thiophene-2-yl-methyl)- delta2-1,2,4-triazoline-5-thiones. Acta Pharm. 2004, 54, 251-260. (Pubitemid 39390068)
39. Kajiyama, T.; Ohkatsu, Y. Effect of meta-substituents of phenolic antioxidants-Proposal of secondary substituent effect. Polym. Degrad. Stab. 2002, 75, 535-542. (Pubitemid 34100056)
40. Hossain, M.; Shaha, S.; Aziz, F. Antioxidant potential study of some synthesized N-heterocycles. Bangladesh Med. Res. Counc. Bull. 2009, 35, 49-52.
41. Ferreira, I.; Queiroz, M.; Vilas-Boas, M.; Estevinho, L. Evaluation of the antioxidant properties of diarylamines in the benzo [b] thiophene series by free radical scavenging activity and reducing power. Bioorg. Med. Chem. Lett. 2006, 16, 1384-1387.
42. Accelrys Homepage. Available online: http://accelrys.com/ (accessed on 12 January 2012).
43. Phillips, E.; Wasson, R.C. Phenols as corrosion inhibitors and antioxidants. EP330613A2, 30 August 1989.
44. Macleay, R.E.; Myers, T.N. Multipurpose polymer bound stabilizers. EP303986A2, 7 July 1993.
45. Akinchan, N.T.; West, D.X.; Yang, Y.; Salberg, M.M.; Klein, T.L. Magnetic and spectroscopic properties of copper(II) complexes with 1-salicoyl-4- phenylthiosemicarbazide. Transit. Met. Chem. 1995, 20, 481-484.
46. Angelusiu, M.V.; Almajan, G.L.; Rosu, T.; Negoiu, M.; Almajan, E.-R.; Roy, J. Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: Synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60. Eur. J. Med. Chem. 2009, 44, 3323-3329.
47. Jampílek, J.; Doležal, M.; Kuneš, J.; Raich, I.; Liška, F. 4-substituted aryl bromides coupling with 4-methoxybenzene-1- thiol by means of copper catalysts. Chem. Papers 2005, 59, 178-181.
48. PharmaExpert. Available online: http://www.pharmaexpert.ru/passonline/ (accessed on 4 March 2012).
49. Parasuraman, S. Prediction of activity spectra for substances. J. Pharmacol. Pharmacother. 2011, 2, 52-53.
50. Stepanchikova, A.V.; Lagunin, A.A.; Filimonov, D.A.; Poroikov, V.V. Prediction of biological activity spectra for substances: Evaluation on the diverse sets of drug-like structures. Curr. Med. Chem. 2003, 10, 225-233.
51. Anzali, S.; Barnickel, G.; Cezanne, B.; Krug, M.; Filimonov, D.; Poroikov, V. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (pass). J. Med. Chem. 2001, 44, 2432-2437. (Pubitemid 32861447)
52. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997, 23, 3-25 (Pubitemid 27046991)
53. Veber, D.F.; Johnson, S.R.; Cheng, H.-Y.; Smith, B.R.; Ward, K.W.; Kopple, K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002, 45, 2615-2623.
54. Tafazoli, S.; Wright, J.S.; O'Brien, P.J. Prooxidant and antioxidant activity of vitamin e analogues and troglitazone. Chem. Res. Toxicol. 2005, 18, 1567-1574. (Pubitemid 41504477)
55. Massaeli, H.; Sobrattee, S.; Pierce, G.N. The importance of lipid solubility in antioxidants and free radical generating systems for determining lipoprotein peroxidation. Free Radic. Biol. Med. 1999, 26, 1524-1530. (Pubitemid 29302286)
56. Bakht, M.A.; Yar, M.S.; Abdel-Hamid, S.G.; Al Qasoumi, S.I.; Samad, A. Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5862-5869.
57. Ingold, K.; Burton, G. Vitamin E: Or why we don't go rancid. J. Chin. Chem. Soc. 1992, 39, 199-204.
58. Mishra, H.; Singh, N.; Lahiri, T.; Misra, K. A comparative study on the molecular descriptors for predicting drug-likeness of small molecules. Bioinformation 2009, 3, 384-388.
59. Lipinski, C.A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 2004, 1, 337-341. (Pubitemid 40186335)
60. Refsgaard, H.H.F.; Jensen, B.F.; Brockhoff, P.B.; Guldbrandt, M.; Christensen, M.S. In silico prediction of membrane permeability from calculated molecular parameters. J. Med. Chem. 2005, 48, 805-811. (Pubitemid 40209102)
61. Wang, R.; Fu, Y.; Lai, L. A new atom-additive method for calculating partition coefficients. J. Chem. Inf. Comput. Sci. 1997, 37, 615-621. (Pubitemid 127603572)
62. Eklund, P.C.; Langvik, O.K.; Warna, J.P.; Salmi, T.O.; Willfor, S.M.; Sjoholm, R.E. Chemical studies on antioxidant mechanisms and free radical scavenging properties of lignans. Org. Biomol. Chem. 2005, 3, 3336-3347. (Pubitemid 41423969)
63. Sharma, O.P.; Bhat, T.K. Dpph antioxidant assay revisited. Food Chem. 2009, 113, 1202-1205.
64. Frankel, E. Lipid Oxidation, 2 ed.; Oily Press Lipid Library Bridgewater: Bridgewater, UK, 2005; Volume 10, pp. 1-470.
65. Nawar, W. Lipids, Chapter 5. In Food Chemistry, 3rd ed.; Fennema, O.R., Ed.; Marcel Dekker, Inc.: New York, NY, USA, 1996; pp. 254-299.
66. Kus, C.; Ayhan-KIlcIgil, G.; Ozbey, S.; Kaynak, F.; Kaya, M.; Çoban, T.; Can-Eke, B. Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2h-1,2,4- triazole-3(4h)-thione derivatives of benzimidazole class. Bioorg. Med. Chem. 2008, 16, 4294-4303. (Pubitemid 351539047)
67. Lucarini, M.; Pedrielli, P.; Pedulli, G.F.; Valgimigli, L.; Gigmes, D.; Tordo, P. Bond dissociation energies of the N-H bond and rate constants for the reaction with alkyl, alkoxyl, and peroxyl radicals of phenothiazines and related compounds. J. Am. Chem. Soc. 1999, 121, 11546-11553.
68. Scott, G. Antioxidants. Bull. Chem. Soc. Jpn. 1988, 61, 165-170. (Pubitemid 18079343)
69. Escobar-Valderrama, J.; Garcia-Tapia, J.; Ramirez-Ortiz, J.; Rosales, M.; Toscano, R.; Valdes-Martinez, J. Crystal, molecular and electronic structure of 1-h-3-methyl-4-amine-5-thione- 1,2,4-triazol. Can. J. Chem. 1989, 67, 198-201.
70. Matsuura, T.; Ohkatsu, Y. Phenolic antioxidants: Effect of O-benzyl substituents. Polym. Degrad. Stab. 2000, 70, 59-63.
71. Amorati, R.; Ferroni, F.; Pedulli, G.F.; Valgimigli, L. Modeling the co-antioxidant behavior of monofunctional phenols. Applications to some relevant compounds. J. Org. Chem. 2003, 68, 9654-9658. (Pubitemid 37509872)
72. Huang, D.; Ou, B.; Hampsch-Woodill, M.; Flanagan, J.; Deemer, E. Development and validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated-cyclodextrin as the solubility enhancer. J. Agric. Food Chem. 2002, 50, 1815-1821. (Pubitemid 34259972)
73. McClements, D.; Decker, E. Lipid oxidation in oil in water emulsions: Impact of molecular environment on chemical reactions in heterogeneous food systems. J. Food Sci. 2000, 65, 1270-1282. (Pubitemid 32102931)
74. Alamed, J. Impact of Chemical and Physical Properties on the Ability of Antioxidants to Inhibit Lipid Oxidation in Foods; University of Massachusetts Amherst, Amherst, MA, USA, 2008.
75. Decker, E.A. Strategies for manipulating the prooxidative/antioxidative balance of foods to maximize oxidative stability. Trends Food Sci. Technol. 1998, 9, 241-248. (Pubitemid 28514662)
76. Khan, I.; Ali, S.; Hameed, S.; Rama, N.; Hussain, M.; Wadood, A.; Uddin, R.; Ul-Haq, Z.; Khan, A. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Eur. J. Med. Chem. 2010, 45, 5200-5207.
77. Hilton, J. Antioxidants: Function, types and necessity of inclusion in pet foods. Can. Vet. J. 1989, 30, 682-684.
78. Bruker. APEX2 and SAINT; Bruker AXS Inc.: Madison, WI, USA, 2007.
79. Sheldrick, G. A short history of shelx. Acta Crystallogr. A 2008, 64, 112-122.
80. Barbour, L.J. X-seed-A software tool for supramolecular crystallography. J. Supramol. Chem. 2001, 1, 189-191. (Pubitemid 33711538)
81. Blois, M.S. Antioxidant determination by the use of a stable free radical. Nature 1958, 181, 1199-1200.
82. Daker, M.; Abdullah, N.; Vikineswary, S.; Goh, P.C.; Kuppusamy, U.R. Antioxidant from maize and maize fermented by Marasmiellus sp. As stabiliser of lipid-rich foods. Food Chem. 2008, 107, 1092-1098 (Pubitemid 350161209)